The European Commission has initiated formal proceedings against Meta, signalling a significant regulatory move in the realm of digital markets. This action underscores the Commission’s commitment to maintaining competitive practices and scrutinising potential monopolistic behaviours within the tech industry. As these proceedings unfold, they will likely have substantial implications for Meta’s operations and the broader...
Category: Policy Updates
NYC Launches Cannabis Fund for Minority Dispensary Ownership
New York City is set to launch a cannabis fund aimed at supporting minority entrepreneurs in the cannabis industry. This innovative program comes as part of the city’s broader efforts to address disparities and create opportunities for marginalised communities disproportionately impacted by past drug policies. The fund will specifically finance the establishment of a social...
SC State House Pushes for Accountability in Fentanyl Deaths
A pivotal bill proposing the establishment of a fentanyl-induced homicide charge is gaining traction in the South Carolina State House, marking a significant step in combating the opioid crisis. The legislation aims to hold drug dealers accountable for overdose deaths caused by fentanyl, a potent synthetic opioid linked to a rising number of fatalities nationwide....
UK Parliament’s Focus on Drug and Alcohol Challenges
In the UK Parliament, Early Day Motions (EDMs) have been instrumental in highlighting critical issues regarding drug and alcohol-related concerns. Led by Dan Carden MP and Rachael Maskell MP, EDM 664 focuses on addressing alcohol-related deaths, emphasising the urgency of altering current trajectories to combat this pressing issue. Concurrently, EDM 662, championed by Rachael Maskell...
UK’s Advocacy for Evidence-Led Drug Policies at UN Commission
Amid the UN Commission on Narcotic Drugs session, Chris Philp MP, Minister for Crime, Policing, and Fire, represented the UK, emphasising a commitment to evidence-based and accessible treatment and recovery services. His attendance underscored the UK’s dedication to aligning policies with informed strategies to address substance dependency effectively. By pledging to prioritise evidence-led interventions and...
Spotlight on Scottish Government’s Financial Disclosures Through Recent FOI Release
The Scottish Government’s commitment to transparency is under examination following a recent freedom of information (FOI) request. This request has unveiled comprehensive details regarding government spending across various sectors, from environmental policies to healthcare funding. The disclosed information reveals not only the breadth of investment areas but also raises questions about the priorities and effectiveness...
Queens Leaders Call for Order in Cannabis Retail Transition
Queens civic leaders are taking a firm stance against the legalisation of pot shops until every illicit marijuana dispensary in the area is shut down, as reported by the New York Post. The community leaders argue that allowing legal cannabis stores to operate while illegal ones remain in business could perpetuate a dual system that...
Louisiana’s Proposed Bills Pose Threat to Delta-8 Market, Hemp Industry
Two separate bills in Louisiana are causing a stir in the hemp industry, as detailed in HempToday. These bills propose to eliminate the market for Delta-8 THC and other hemp intoxicants, citing concerns over public health and safety. If passed, these legislative measures could significantly impact businesses that rely on the production and sale of...
Evaluating the Impact of the 2021-2026 Strategy to Combat Drug Mortality
The comprehensive evaluation of the 2021-2026 National Mission on Drug Deaths, as discussed on DB Recovery Resources, reveals a critical analysis of governmental efforts to tackle the escalating drug mortality rates. Initiated with the ambitious goal of halving drug-related deaths within five years, the mission sought to address this public health crisis through a multidimensional...
DEA Administrator Sidesteps Marijuana Rescheduling Decision
In a recent development that has stirred the pot in drug policy circles, sources within the Drug Enforcement Administration (DEA) have disclosed that DEA Administrator Anne Milgram did not approve the decision to reschedule marijuana. This revelation, highlighted by Dr. Kevin Sabet, a prominent figure in drug policy reform, underscores a significant deviation from longstanding...









